👀 Ones to watch: Undervalued stocks to buy before they report Q3 earningsSee Undervalued Stocks

TD Cowen sets AFLAC shares at Hold rating

EditorTanya Mishra
Published 10/09/2024, 08:27 AM
AFL
-

TD Cowen has initiated coverage on shares of AFLAC Incorporated (NYSE: NYSE:AFL), assigning a Hold rating to the stock with a price target of $102.

This valuation is based on a detailed sum-of-the-parts analysis, which considers projected earnings for the company's product lines in the year 2025, along with adjustments for excess capital, liability exposures, and investments.

The insurance company's price target suggests a blended price-to-earnings (P/E) multiple of 13.9 times the estimated earnings per share (EPS) for 2025.

The Hold rating indicates that TD Cowen views the stock as adequately valued at its current price, suggesting investors maintain their positions without adding more shares or selling existing holdings.

The method used by TD Cowen to arrive at the price target for AFLAC is a common analytical approach in equity research.

By applying P/E multiples to the anticipated earnings from specific product lines, the firm assesses the individual contributions to the company's overall value. Adjustments for factors such as excess capital and liability exposures help refine the valuation to account for financial nuances that may affect the company's fiscal health and performance.

In other recent news, AFLAC Incorporated has demonstrated a strong financial performance in the second quarter of 2024, with a significant increase in net earnings per diluted share, standing at $3.10 for the quarter.

Adjusted earnings per diluted share also rose by 15.8% to $1.83, indicating robust growth in both the Japanese and U.S. markets due to new product introductions and a focus on third-sector products. The company also repurchased $800 million in shares and paid dividends of $283 million during the quarter.

Evercore ISI has adjusted its price target for AFLAC shares to $90 from the previous $84 while maintaining an Underperform rating. This revision reflects the company's capital generation and return potential, along with a forecast for a recovery in health insurance sales in 2025 and 2026. However, Evercore ISI remains cautious due to perceived risks associated with the Japanese first sector sales rollout.

Concurrently, BofA Securities has raised its price target for AFLAC to $115.00 from $108.00, maintaining a Buy rating. The adjustment is mainly due to an increase in the firm's EPS forecast, which remains the highest projection on Wall Street.

Despite concerns over AFLAC's exposure to the transitional commercial real estate market, BofA Securities anticipates that this issue may become less significant in a lower interest rate environment.

InvestingPro Insights

AFLAC's financial metrics and recent performance offer additional context to TD Cowen's Hold rating and $102 price target. According to InvestingPro data, AFLAC's current P/E ratio stands at 11.91, which is lower than the 13.9 times 2025 estimated EPS used in TD Cowen's valuation. This suggests the stock might be undervalued based on current earnings.

InvestingPro Tips highlight AFLAC's strong dividend history, noting that the company "has raised its dividend for 40 consecutive years" and "has maintained dividend payments for 52 consecutive years." This impressive track record of dividend growth and stability could be attractive to income-focused investors, potentially supporting the stock's valuation.

The company's recent performance has been robust, with InvestingPro data showing a 27.08% price total return over the past three months and a 47.04% return over the past year. These strong returns align with the InvestingPro Tip that AFLAC is "trading near 52-week high," which may factor into TD Cowen's decision to initiate coverage with a Hold rating rather than a Buy.

For investors seeking a more comprehensive analysis, InvestingPro offers 11 additional tips for AFLAC, providing a deeper understanding of the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.